Valuation DexCom, Inc. Deutsche Boerse AG
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.90 EUR | -2.59% |
|
+4.21% | +12.94% |
| Jul. 29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| Jul. 29 | Alert from law firm on Dexcom withdrawn | RE |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 28,994 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 12.01% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 28,491 | 27,659 | 26,692 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 8.71% | -2.92% | -3.5% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 30.5x | 25.6x | 21.2x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 9.32x | 7.46x | 5.67x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.7x | 1.3x | 1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.55x | 4.98x | 4.46x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.45x | 4.75x | 4.11x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.4x | 14.5x | 12.1x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 23.5x | 19.2x | 15.5x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 28.7x | 22.3x | 17.6x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.49% | 4.49% | 5.68% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.462 | 2.938 | 3.537 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,224 | 5,824 | 6,498 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,641 | 1,914 | 2,207 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,723 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 963.1 | 1,163 | 1,393 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -504 | -1,336 | -2,303 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 75.14 | 75.14 | 75.14 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.92x | 4.2x | 16.3x | 2.39% | 187B | |
| 19.84x | 3.45x | 12.15x | 3.4% | 112B | |
| 17.72x | 0.2x | 12.49x | 0.74% | 61.99B | |
| 29.98x | 7.26x | 18.97x | 1.34% | 48.52B | |
| 36.67x | 3.26x | 11.11x | 2.33% | 46.4B | |
| 38.42x | 1.4x | 12.29x | 0.2% | 33.89B | |
| 39.35x | 6.89x | 24.68x | 0.27% | 23.75B | |
| 25x | 3.79x | 13.27x | 1.11% | 22.89B | |
| 20.89x | 2.89x | 11.15x | 1.51% | 21.45B | |
| Average | 28.76x | 3.70x | 14.71x | 1.48% | 61.98B | |
| Weighted average by Cap. | 27.81x | 3.67x | 14.63x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
